These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10373186)

  • 1. Audit of use of ACE inhibitors and monitoring in general practice. Guidelines on monitoring, on their own, are not sufficient.
    Freemantle N; Mason J; Eccles M
    BMJ; 1999 Jun; 318(7199):1697. PubMed ID: 10373186
    [No Abstract]   [Full Text] [Related]  

  • 2. Questionnaire study and audit of use of angiotensin converting enzyme inhibitor and monitoring in general practice: the need for guidelines to prevent renal failure.
    Kalra PA; Kumwenda M; MacDowall P; Roland MO
    BMJ; 1999 Jan; 318(7178):234-7. PubMed ID: 9915733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE inhibitors and heart failure in hospital: any difference between cardiologists and general physicians?
    Davie AP; McMurray JJ
    Postgrad Med J; 1999 Apr; 75(882):219-2. PubMed ID: 10715761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AHCPR guidelines on heart failure: comparison of a family medicine and an internal medicine practice with the guidelines and an educational intervention to modify behavior.
    Chodoff P; Bischof RO; Nash DB; Laine C
    Clin Perform Qual Health Care; 1996; 4(4):179-85. PubMed ID: 10162148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceived barriers for treatment of chronic heart failure in general practice; are they affecting performance?
    Kasje WN; Denig P; de Graeff PA; Haaijer-Ruskamp FM
    BMC Fam Pract; 2005 May; 6(1):19. PubMed ID: 15869704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No consensus on withholding angiotensin-converting enzyme inhibitors and angiotensin receptor blockers before spinal anaesthesia.
    Bøgebjerg MK
    Dan Med J; 2012 Dec; 59(12):A4543. PubMed ID: 23290284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines.
    Dicpinigaitis PV
    Chest; 2006 Jan; 129(1 Suppl):169S-173S. PubMed ID: 16428706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACE inhibitors vs. angiotensin II receptor blockers in acute myocardial infarction and heart failure.
    Gold JA; Rahko PS
    WMJ; 2004; 103(1):71-2. PubMed ID: 15101473
    [No Abstract]   [Full Text] [Related]  

  • 9. [ACE inhibitor or ATII receptor blocker in heart failure and myocardial infarction?].
    Landmark K; Reikvam A
    Tidsskr Nor Laegeforen; 2005 Jan; 125(1):38-40. PubMed ID: 15643463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of angiotensin-converting-enzyme inhibitors in the treatment of hypertension.
    Hilleman DE
    Am J Health Syst Pharm; 2000 Oct; 57 Suppl 1():S8-11. PubMed ID: 11030017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ACE inhibitors and AT-II antagonists--do they protect against renal disease?].
    Rossing P; Parving HH
    Ugeskr Laeger; 2006 Apr; 168(15):1564; author reply1564-5. PubMed ID: 16640990
    [No Abstract]   [Full Text] [Related]  

  • 12. ACE inhibitor therapy: benefits and underuse.
    Smith SC
    Am Fam Physician; 1999 Jan; 59(1):35-6, 38. PubMed ID: 9917572
    [No Abstract]   [Full Text] [Related]  

  • 13. [Patients with heart failure should primarily be treated with ACE inhibitors].
    Johansson M
    Lakartidningen; 2004 Apr; 101(17):1536; discussion 1537-8. PubMed ID: 15150959
    [No Abstract]   [Full Text] [Related]  

  • 14. ACE-inhibition for secondary prevention of cardiovascular events--should we change our recommendation after PEACE?
    Ferrari R
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):11-2. PubMed ID: 16649066
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of a clinical audit to promote the quality use of medicines to rural and remote general practitioners.
    Cutts C
    Aust J Rural Health; 2001 Dec; 9 Suppl 1():S49-53. PubMed ID: 11998277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The current role of ACE-inhibitors for secondary prevention in cardiovascular disease; from pathogenesis to clinical practice.
    Voors AA; van Veldhuisen DJ; van Gilst WH
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):69-73. PubMed ID: 16619108
    [No Abstract]   [Full Text] [Related]  

  • 17. An audit of echocardiograms in acute left ventricular failure.
    Morgan R; King D
    Postgrad Med J; 1995 Dec; 71(842):738-40. PubMed ID: 8552538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-reported prescribing for hypertension in general practice.
    O'Riordan S; Mackson J; Weekes L
    J Clin Pharm Ther; 2008 Oct; 33(5):483-8. PubMed ID: 18834362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of ACE inhibitors and ARBs in hypertensive women of childbearing age.
    Martin U; Foreman MA; Travis JC; Casson D; Coleman JJ
    J Clin Pharm Ther; 2008 Oct; 33(5):507-11. PubMed ID: 18834365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.